@article{05bef9b2196d47eaae412d9e5ca1040c,
title = "Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis",
abstract = "Dietary therapy for short- and long-term management of eosinophilic esophagitis is an effective yet poorly understood and underutilized treatment strategy. Despite several prospective trials demonstrating the efficacy of dietary therapies, successful clinical implementation is hampered by the need for a multidisciplinary approach including dietitian support and provider expertise. The availability of these resources is not readily available to most gastroenterologists. Without standardized guidance on starting or completing the diet for gastrointestinal providers and/or consulting dietitians, provider attitudes toward dietary therapy vary greatly depending on familiarity and knowledge gaps in using diet therapy. This review aims to summarize evidence in support of dietary therapy in eosinophilic esophagitis while providing guidance on initiation and implementation of dietary therapy for providers.",
keywords = "Elimination Diet, Eosinophil, Esophagus, Food Allergen, Food Reintroduction, Nutrition",
author = "{Consortium of Eosinophilic Gastrointestinal Disease Researchers} and Chang, {Joy W.} and Kara Kliewer and Emily Haller and Amanda Lynett and Bethany Doerfler and Katzka, {David A.} and Peterson, {Kathryn A.} and Dellon, {Evan S.} and Nirmala Gonsalves and Aceves, {Seema S.} and Pablo Abonia and Dan Atkins and Bonis, {Peter A.} and Mirna Chehade and Falk, {Gary W.} and Furuta, {Glenn T.} and Gupta, {Sandeep K.} and Kagalwalla, {Amir F} and Ellyn Kodroff and Scholeigh Kyle and John Leung and Paul Menard-Katcher and Sabina Mir and Mukkada, {Vincent A.} and Robert Pesek and Rothenberg, {Marc E.} and Spergel, {Jonathan M.} and Strobel, {Mary Jo} and Wechsler, {Joshua B.}",
note = "Funding Information: Funding Joy W. Chang is supported by funding in part by National Institutes of Health award K23DK129784 and a training grant from the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) (U54AI117804), which is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research. CEGIR is also supported by patient advocacy groups including American Partnership for Eosinophilic Disorders, Campaign Urging Research for Eosinophilic Diseases, and Eosinophilic Family Coalition. As a member of the Rare Disease Clinical Research Network, CEGIR is also supported by its Data Management and Coordinating Center (U2CTR002818). Funding Information: Funding Joy W. Chang is supported by funding in part by National Institutes of Health award K23DK129784 and a training grant from the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) ( U54AI117804 ), which is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research. CEGIR is also supported by patient advocacy groups including American Partnership for Eosinophilic Disorders, Campaign Urging Research for Eosinophilic Diseases, and Eosinophilic Family Coalition. As a member of the Rare Disease Clinical Research Network, CEGIR is also supported by its Data Management and Coordinating Center (U2CTR002818). Publisher Copyright: {\textcopyright} 2023 The Authors",
year = "2023",
month = jul,
doi = "10.1016/j.cgh.2023.03.006",
language = "English (US)",
volume = "21",
pages = "1690--1698",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders",
number = "7",
}